News

Defensive Medicine, Malpractice Nab 10% of Premium Dollars


 

WASHINGTON — The costs of malpractice insurance and defensive medicine account for about 10 cents of every dollar spent on health care premiums, several speakers said at a press briefing sponsored by America's Health Insurance Plans.

Medical liability and defensive medicine represented the “lion's share” of cost increases in the physician and outpatient areas, Michael Thompson, principal at the New York office of PricewaterhouseCoopers (PWC), said at the briefing. Litigation and defensive medicine also accounted for about a third of the costs associated with poor-quality health care, said Mr. Thompson, noting that the cost of poor-quality care was spread throughout the health care system.

Karen Ignagni, AHIP president, said efforts must be made to reduce the amount of poor-quality care being given. “We have a system where 45% of what's being done is not best practice,” she said. “No public or private entity could operate at that rate.”

The rate of increase in health care premiums was 8.8% in 2004–2005, down significantly from 13.7% in 2001–2002, noted Jack Rodgers, managing director at PWC. One factor contributing to the slowdown was a decrease in the rate of cost increases for prescription drugs, said Mr. Thompson. Part of the reason for that decrease is employers' increasing use of three- or four-tiered drug programs, in which patients pay a larger share for brand-name drugs, especially if there are generic equivalents. In 2000, only 27% of patients were in drug plans with three or more tiers; in 2004, 68% were, he said, adding that cost trends were also aided by a drop in the number of state mandates being added each year, from 80 in 2000 to fewer than 40 in 2004.

Outpatient costs rose significantly last year, Mr. Rodgers said, accounting for more than a third of the 8.8% increase in premiums, he noted.

Despite these problems, Mr. Thompson said in an interview that he did not expect premium increases to go higher next year. Part of the stabilization will likely be due to consumers having to pay more for their health care costs and becoming more aware of prices as a result, he added.

Recommended Reading

Two Trials Result in Two Very Different Vioxx Verdicts
MDedge Cardiology
CMS 'E-Prescribing' Rule Presents Big Challenges
MDedge Cardiology
Policy & Practice
MDedge Cardiology
Drug Discount Program Offers Lessons for CMS
MDedge Cardiology
Cost Is One Snag of Voluntary Reporting Program : Some worry the new 4.4% cut in physicians' pay will make it even harder to comply with reporting.
MDedge Cardiology
EMR Success Varies With Size of Cardiology Practice
MDedge Cardiology
Goals Set for Making Electronic Health Records More Accessible
MDedge Cardiology
A Step-by-Step Approach Will Ease the Shift to EMRs
MDedge Cardiology
Medicare Audit Policy Is Questioned
MDedge Cardiology
Policy & Practice
MDedge Cardiology